At the news
? NEUTRALIMPACT 2/10 144 filed Nov 5, 2026 at 15:10 ET
Martin Wilson, an officer of Rocket Pharmaceuticals, filed a Form 144 notice to sell 53,389 shares of common stock, valued at approximately $127,808 based on the filing date price. The shares were acquired via restricted stock vesting on November 4, 2026, and the sale appears to be a routine transaction to cover tax obligations from equity award settlement, as indicated by similar prior sales.
- Officer Martin Wilson filed Form 144 to sell 53,389 shares of common stock.
- Estimated aggregate market value of the sale is $127,807.93.
- Shares were acquired via restricted stock vesting on November 4, 2026.
- The sale is intended to be executed through Fidelity Brokerage Services LLC.
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access